Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Imc Mortgage Co
IMCC | US
0.75
USD0.06
8.70%
IMCC | US
About Imc Mortgage Co
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/06/2024
As of date
06/03/2026
Close
0.75
Open
0.70
High
0.77
Low
0.68
IM Cannabis Corp. engages in breeding growing and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower pre-rolls minis and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv Israel.
View LessIMCC | US
Risk
75.6
Sharpe
-0.44
Luna's Score
42/100
Recommendation
Sell
Luna says (IMCC | US)
What's Working
Strength based on increasing price with high volume
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
94.4%1 month
75.6%3 months
90.0%6 months
101.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
16.31
Price to book
0.90
Debt to equity
2.23
Debt to assets
0.39
Ent. to EBITDA
-1.31
Ent. to rev.
0.43
PEG
-
Other Fundamentals
EBITDA
-11.03M
MarketCap
1.70M
MarketCap(USD)
1.70M
Div. yield
-
Op. margin
-19.58
Erngs. growth
-
Rev. growth
11.70
Ret. on equity
-112.01
Short ratio
0.26
Short perc.
0.23
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.31
Range1M
0.60
Range3M
1.43
Volumes: Market Activity
Rel. volume
1.57
Price X volume
62.19K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.31 | 24.85 | Cheaper |
| Ent. to Revenue | 0.43 | 361.91 | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 0.90 | 13.15 | Cheaper |
| Dividend Yield | - | 2.94 | - |
| Std. Deviation (3M) | 90.01 | 65.24 | Riskier |
| Debt to Equity | 2.23 | -1.88 | Expensive |
| Debt to Assets | 0.39 | 0.48 | Par |
| Market Cap | 1.70M | 3.71B | Emerging |
